Hbt Labs Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HBT LABS INC, and what generic and branded alternatives to HBT LABS INC drugs are available?
HBT LABS INC has one approved drug.
Drugs and US Patents for Hbt Labs Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hbt Labs Inc | FULVESTRANT | fulvestrant | SOLUTION;INTRAMUSCULAR | 209714-001 | Nov 21, 2019 | AO | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.